The effect of 1.5 T cardiac magnetic resonance on human circulating leucocytes

William R Critchley1,2, Anna Reid3,4, Julie Morris5

  • 1Manchester Collaborative Centre for Inflammation Research (MCCIR), Division of Infection, Immunity and Respiratory Research, School of Biology, Medicine and Health, Manchester Academic Health Science Centre, Room 2.12 Core Technology Facility, Grafton Street, University of Manchester, M13 9NT Manchester, UK.

European Heart Journal
|November 23, 2017
PubMed

Insights

Cardiovascular magnetic resonance (CMR) did not damage DNA or affect white blood cell (leukocyte) function in lab tests or patients. However, CMR was linked to a reduction in circulating T cells in patients.

Area of Science:

  • Medical Imaging
  • Biophysics
  • Hematology

Background:

  • Cardiovascular magnetic resonance (CMR) is a non-ionizing imaging technique.
  • Concerns exist regarding potential biological effects of CMR, prompting comparisons to ionizing radiation techniques.
  • Investigating CMR's acute effects on cellular components is crucial for safety assessments.

Purpose of the Study:

  • To evaluate the acute impact of 1.5 Tesla CMR on leukocyte DNA integrity, cell counts, and function.
  • To assess these effects both in vitro using isolated cells and in vivo in a patient cohort.

Main Methods:

  • In vitro: Peripheral blood mononuclear cells (PBMCs) from healthy volunteers were analyzed for histone H2AX phosphorylation (γ-H2AX) and functional parameters post-CMR exposure.
  • In vivo: Blood samples from 64 patients were collected before and after a standard CMR scan to measure γ-H2AX expression and leukocyte counts.
  • Flow cytometry was the primary technique for quantifying cellular changes and DNA damage markers.

Main Results:

  • CMR exposure did not induce significant DNA damage (γ-H2AX expression) in vitro or in vivo.
  • In vitro, cell integrity and function of PBMCs remained unchanged after CMR.
  • A statistically significant reduction in circulating T cells was observed in vivo following CMR, with marked inter-patient variations in γ-H2AX.
  • Inter-individual variability in γ-H2AX necessitates caution when interpreting this marker in small studies.

Conclusions:

  • 1.5T CMR is not associated with DNA damage in leukocytes, either in vitro or in vivo.
  • CMR does not impair leukocyte viability or function in laboratory settings.
  • A significant decrease in viable leukocytes, particularly T cells, occurs in vivo after CMR exposure.
  • The significant inter-patient variability in γ-H2AX suggests it may not be a universally reliable biomarker for CMR-induced DNA damage.
Abstract